June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Herc3 mutations lead to prominent retinal microglial/macrophage activation and retinal degeneration.
Author Affiliations & Notes
  • Yeshumenesh Zegeye
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Bogale Aredo
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Seher Yuksel
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Emily Turpin
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Sangita Shrestha
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Sara Ludwig
    Center for the Genetics of Host Defense, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Bruce Beutler
    Center for the Genetics of Host Defense, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Rafael Ufret-Vincenty
    Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Footnotes
    Commercial Relationships   Yeshumenesh Zegeye None; Bogale Aredo None; Seher Yuksel None; Emily Turpin None; Sangita Shrestha None; Sara Ludwig None; Bruce Beutler None; Rafael Ufret-Vincenty None
  • Footnotes
    Support  NEI grant-1R01EY033181, National Eye Institute Visual Science Core Grant P30 EY030413, NIH grants R01 AI125581 and U19 AI100627
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1587. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yeshumenesh Zegeye, Bogale Aredo, Seher Yuksel, Emily Turpin, Sangita Shrestha, Sara Ludwig, Bruce Beutler, Rafael Ufret-Vincenty; Herc3 mutations lead to prominent retinal microglial/macrophage activation and retinal degeneration.. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1587.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To corroborate that Herc3 is essential to retinal homeostasis and start exploring the mechanisms explaining its role in retinal physiology.

Methods : Using an unbiased forward genetics approach to screen for genes associated to retinal fundus spot accumulation and retinal thinning we identified Herc3 as a gene of interest. Here we characterize Herc3 KO mice using fundus photography, OCT, immunohistochemistry, electrophysiology, electron microscopy, bulk RNA sequencing and Western blot (WB).

Results : The aegean phenotype seen in the forward genetics screen was recapitulated in the CRISPR-generated KO mouse line. This included accumulation of retinal fundus spots with age and a statistically significant thinning of the outer retina. Furthermore, progressive accumulation of activated subretinal microglia/macrophages and decreased ERG signal were seen. Proteomics analysis demonstrated significant protein expression differences in Herc3 KO mice compared to age-matched controls. A decrease in overall ubiquitination was seen in WB, suggesting that the role of Herc3 as an E3 ubiquitin ligase may be important to retinal physiology.

Conclusions : A forward genetics screening protocol allowed us to identify a novel association of Herc3 to retinal homeostasis. Despite being only one of multiple E3 ubiquitin ligases in the retina, Herc3 has a non-redundant role in the regulation of retinal microglial/macrophage activation and in preventing retinal degeneration. Since the ubiquitin proteasome system is important in many cellular functions, including cell cycle control, signal transduction, and removal of toxic/damaged proteins from the cell, further studies will be needed to further characterize the specific role of this gene in retinal homeostasis.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×